中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 1,3-bis[4-(bromomethyl)phenyl]benzene | 19399-69-0 | C20H16Br2 | 416.155 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 12,28-Diazaheptacyclo[28.2.2.27,10.214,17.223,26.12,6.118,22]dotetraconta-1(32),2(42),3,5,7(41),8,10(40),11,14(39),15,17(38),18,20,22(37),23,25,28,30,33,35-icosaene | 1422357-38-7 | C40H30N2 | 538.692 |
—— | 12,19,35,42-Tetrazanonacyclo[42.2.2.27,10.214,17.221,24.230,33.237,40.12,6.125,29]hexaconta-1(46),2(60),3,5,7(59),8,10(58),12,14(57),15,17(56),18,21(55),22,24(54),25,27,29(53),30,32,35,37,39,41,44,47,49,51-octacosaene | 1422357-40-1 | C56H44N4 | 772.992 |
—— | 7,23-Diazahexacyclo[23.2.2.22,5.29,12.218,21.113,17]hexatriaconta-1(28),2(36),3,5(35),9,11,13(32),14,16,18(31),19,21(30),25(29),26,33-pentadecaene-6,24-dione | 1350313-04-0 | C34H26N2O2 | 494.593 |
—— | 12,21,37,46-Tetrazanonacyclo[46.2.2.27,10.223,26.232,35.12,6.127,31.014,19.039,44]hexaconta-1(50),2(60),3,5,7(59),8,10(58),12,14,16,18,20,23(57),24,26(56),27,29,31(55),32,34,37,39,41,43,45,48,51,53-octacosaene | 1422357-39-8 | C56H44N4 | 772.992 |
—— | 12,20,36,44-Tetrazanonacyclo[44.2.2.27,10.222,25.231,34.12,6.114,18.126,30.138,42]hexaconta-1(48),2(60),3,5,7(59),8,10(58),14(57),15,17,22(56),23,25(55),26,28,30(54),31,33,38,40,42(51),46,49,52-tetracosaene-13,19,37,43-tetrone | 1350313-00-6 | C56H44N4O4 | 836.99 |
The synthesis of novel N-tosyl tetraaza cyclophanes and N-tosyl diaza cyclophane incorporating m-terphenyl as spacer units is described. Anti-arthritic activity was studied by inhibition of the protein denaturation method (bovine serum albumin). All the N-tosyl aza cyclophanes exhibit excellent anti-arthritic activity. Anti-inflammatory activity of the synthesized cyclophanes was investigated using the human red blood cells (HRBC) membrane stabilization method and some of the N-tosyl aza cyclophanes exhibited good anti-inflammatory activity.
The synthesis and structural characterisation of novel imino cyclophanes incorporating various spacer units is described. All the imino cyclophanes exhibit comparable antibacterial activity against Gram positive (Bacillus subtillus, Staphylococcus aureus) and Gram negative (Escherchia coli, Klebsiella pneumonia) bacterial strains. The imino cyclophanes also exhibit good antifungal activity against human pathogenic fungus, Candida albicans.